Summary
- Merck & Co. has agreed to acquire the Antelliq Group for up to $3.72 billion in cash and debt assumption.
- Antelliq provides animal monitoring technologies for commercial and personal animal markets.
- Merck will combine Antelliq with its Animal Health division as it pursues a more integrated approach to fast-growing animal health markets worldwide.
- Looking for a community to discuss ideas with? IPO Edge features a chat room of like-minded investors sharing investing ideas and strategies. Get started today »
Merck (MRK) announced it has agreed to acquire Antelliq Group for $3.72 billion in total consideration and debt assumption.
Antelliq Group provides digital animal identification, monitoring, and traceability solutions.
MRK is acquiring Antelliq to integrate its digital tracking capabilities within its Animal Health division to provide customers and prospects with a fully integrated solution.
